Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab.

NCT01068132 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Cetuximab
DRUG: FOLFIRI

Sponsor

Regione Lombardia

Collaborators

[object Object]
[object Object]
[object Object]